348
Participants
Start Date
April 8, 2015
Primary Completion Date
May 31, 2027
Study Completion Date
May 31, 2032
Bleomycin Etoposide and Cisplatin
Carboplatin
Institutt for kreftforskning og molekylær medisin, St Olavs Hospital, Trondheim
St. Olavs University hospital HF, Trondheim
Haukeland University Hospital
OTHER
University Hospital of North Norway
OTHER
Sahlgrenska University Hospital
OTHER
Karolinska Institutet
OTHER
Oslo University Hospital
OTHER
Uppsala University Hospital
OTHER
University Hospital, Linkoeping
OTHER
Skane University Hospital
OTHER
Norrlands University Hospital
OTHER
St. Olavs Hospital
OTHER